The Gastroenterology and Hepatology department provides tertiary-level care for patients from across Western Australia with gastrointestinal and liver problems. 

Our clinical services include: 

• Specialty inpatient management 
• Consultative support to other medical and surgical disciplines 
• Outpatient care 
• Tertiary-level endoscopic services 

Research interests and focus

Our department has an extensive clinical research program, being involved in multiple international and national research studies, in addition to collaborative research studies with other institutions in Western Australia. 

Example projects 

A Phase 3 Double-blinded, Two-arm Study to Evaluate the Safety and Efficacy of Pembrolizumab (MK-3475) versus Placebo as Adjuvant Therapy in Participants with Hepatocellular Carcinoma and Complete Radiological Response after Surgical Resection or Local Ablation (KEYNOTE-937)
CPI: Dr Simone Strasser (Royal Prince Alfred Hospital, Sydney)
EMHS contact: Dr Adam Doyle (EMHS

---

A phase 3, randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of Efruxifermin in subjects with non-cirrhotic non-alcoholic steatohepatitis (NASH)/metabolic dysfunction-associated steatohepatitis (MASH) and fibrosis
CPI: Dr Stephen Pianko (Monash Health, Melbourne)
EMHS contact: Dr Nick Kontorinis (EMHS)

A Phase 3 Study to Evaluate the Efficacy and Safety of Pegozafermin in Subjects with Compensated Cirrhosis due to Metabolic Dysfunction-Associated Steatohepatitis (MASH)
CPI: Dr Marno Ryan (St Vincents Hospital, Melbourne)
EMHS contact: Dr Kontorinis (EMHS)